Allergan Inc 

AGN:NYSE

LastChange / % ChangeDividend YieldVolumeAvg Volume (10 day)
91.97 0.17   0.19%0.22%1,608,2892.4M

Market data is delayed by at least 20 minutes.
Previous close 7/19/2013
 
 
 

Latest News Headlines for Allergan Inc

No News for Allergan Inc
 
 
 
 
 
 
More Filings

Latest Annual and Quarterly SEC Filings

10-K
February 26, 2013
This report contains detailed information about the company's business finances and management.
10-Q
May 7, 2013
Quarterly reports contain financial statement, a discussion from management and a list of company events (stock splits, acquisitions, etc.)
 
 
 
Company Background
Allergan, Inc., is a multi-specialty health care company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. The Company operates in two segments: specialty pharmaceuticals and medical devices. On June 17, 2011, it acquired Alacer Biomedical, Inc. (Alacer). On August 8, 2011, it acquired Precision Light, Inc. (Precision Light). On July 22, 2011, it acquired Vicept Therapeutics, Inc. (Vicept). During the year ended December, 31, 2011, it discontinued its EasyBand Remote Adjustable Gastric Band System. In February 2011, it discontinued the United States sales of Zymar. In December 2012, the Company acquired SkinMedica, Inc. Effective March 1, 2013, Allergen Inc acquired the entire share capital of MAP Pharmaceuticals Inc. Effective March 1, 2013, Allergen Inc acquired the entire share capital of MAP Pharmaceuticals Inc.

Bid/Size
-- / --
Ask/Size
-- / --
Price Open
91.99
Previous Close
91.80
Day High
92.15
Day Low
90.02
52wk High/Date
116.45 / 4/11/2013
52wk Low/Date
81.28 / 7/31/2012
% off 52wk High
-21.02%
% off 52wk Low
13.15%
Beta (5 Yr)
0.8
Market Capitalization
27.3B
Shares Outstanding
296.4M
Volatility Avg
26.19
EPS(TTM)
3.74
P/E Ratio
24.6x
Dividend Announcement
5/1/2013
Dividend Yield
0.22%
Ex-Date
5/21/2013
Date of Record
5/23/2013
Payable
0.05 - QRTR
Payable Date
6/13/2013
Last Trade as of 7/19/2013 4:01 PM ET
 
 
 

AGN Allergan Inc vs. Peers

Peers 
AGN
Allergan Inc
0.26%
Pfizer Inc.
15.99%
Merck & Co., Inc.
16.73%
AGN
Allergan Inc
0.22%
Pfizer Inc.
3.30%
Merck & Co., Inc.
3.60%
AGN
Allergan Inc
0.19%
Pfizer Inc.
2.11%
Merck & Co., Inc.
0.82%
Compare these stocks